Algert Global LLC Kala Pharmaceuticals, Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $11,824 - $51,634	-39,416 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.61 - $1.84 $24,043 - $72,525	39,416 New	39,416 $54,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $27,415 - $64,757	-23,634 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $128,002 - $265,288	-48,856 Reduced 67.4%	23,634 $62,000
Q2 2021 Aug 13, 2021	BUY	$5.06 - $8.15 $296,465 - $477,508	58,590 Added 421.51%	72,490 $384,000

Q1 2021 May 14, 2021	BUY	$6.24 - $9.58 $86,736 - $133,162	13,900 New	13,900 $94,000
Q1 2020 May 13, 2020	SELL	$3.83 - $8.79 $180,756 - $414,844	-47,195 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.57 - $6.58 $168,486 - $310,543	47,195 New	47,195 $180,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.